Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Gleevec (Imatinib Mesylate) Tablets
Company:  Novartis Pharmaceuticals Corp.
Application No.:  021588
Approval Date: 12/8/2003


Date created: April 052005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.